CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery

The purpose of this study is to analyze the efficacy and accuracy of real-time continuous glucose monitoring devices (rtCGM) in patients with Type 2 diabetes undergoing inpatient elective hip or knee surgery in the pre-, peri-, and post-operative setting at Stony Brook University Hospital (SBUH).

Inclusion Criteria:Greater than or equal to 18 years of ageScheduled for elective inpatient hip or knee replacement surgery at Stony Brook University Hospital (SBUH)Clinically diagnosed Type 2 Diabetes at least 6 months prior to surgeryLiterate and able to provide written informed consentNegative pregnancy test by serum or urine HCG at screening [as documented in subject's medical record) for women of childbearing potential (WCBP)]Exclusion Criteria:Less than 18 years of ageNot scheduled for elective inpatient hip or knee replacement surgery at SBUHNo clinical diagnosis of Type 2 diabetes at least 6 months prior to surgeryNot literate or unable to provide written informed consentDocumented diagnosis of organ failureDocumented diagnosis of chronic infectionDocumented diagnosis of any active malignancyDocumented diagnosis of hepatic (liver) dysfunction or cirrhosisPregnant by serum or urine HCG at screening [as documented in subject's medical record) for women of childbearing potential (WCBP)]